Limits...
Addition of epidermal growth factor improves the rate of sulfur mustard wound healing in an in vitro model.

Henemyre-Harris CL, Adkins AL, Chuang AH, Graham JS - Eplasty (2008)

Bottom Line: EGF (1 ng/mL) significantly increased wound fill on all of the days tested (days 6, 9, and 12).KGF did not significantly improve wound healing.These results will be used to develop a dressing that can slowly release EGF on to a debrided wound bed to help speed the healing process.

View Article: PubMed Central - PubMed

Affiliation: Physiology and Immunology Branch, Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA. claudia.henemyre@us.army.mil

ABSTRACT

Objective: Sulfur mustard (SM) causes blisters on the human skin. These blisters delay healing of the skin and make the victims more susceptible to infection. In vitro models have been used for protection studies against SM injury, but study on wound healing after SM exposure has not been explored. The purpose of this study was to test whether the addition of exogenous growth factors could improve the rate of SM wound healing.

Methods: The model consisted of normal human epidermal keratinocytes seeded into 6-well plates, exposed to SM, and wounded (disruption of the cell monolayer) with a sterile wounding instrument. Cells were then stained and images were captured to measure percentage wound fill. Epidermal growth factor (EGF) and keratinocyte growth factor (KGF) were tested in this model.

Results: EGF (1 ng/mL) significantly increased wound fill on all of the days tested (days 6, 9, and 12). KGF did not significantly improve wound healing.

Conclusions: EGF showed promise as a potential therapy for SM-induced wounds. This in vitro model was a valuable tool for screening therapeutics before animal testing. These results will be used to develop a dressing that can slowly release EGF on to a debrided wound bed to help speed the healing process.

No MeSH data available.


Related in: MedlinePlus

NHEK cells exposed to 5 μM of SM and treated with EGF. Cells were treated daily with 0, 1, 10, or 20 ng/mL of EGF and stained with 0.1% crystal violet 6 days after wounding. For 0 μM of SM, a significant difference* (P ≤ .05) in wound fill was observed between the cells treated with 0 ng/mL of EGF and the 1, 10, and 20 ng/mL of EGF groups. For 5 μM of SM, cells treated with 1 ng/mL of EGF had the greatest percentage of wound fill, but no statistically significant differences were observed between the EGF treatment groups. Data points represent mean values ± SEM of 3 determinations. A 1-factor ANOVA was used to compare treatment groups at each SM concentration.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2289780&req=5

Figure 1: NHEK cells exposed to 5 μM of SM and treated with EGF. Cells were treated daily with 0, 1, 10, or 20 ng/mL of EGF and stained with 0.1% crystal violet 6 days after wounding. For 0 μM of SM, a significant difference* (P ≤ .05) in wound fill was observed between the cells treated with 0 ng/mL of EGF and the 1, 10, and 20 ng/mL of EGF groups. For 5 μM of SM, cells treated with 1 ng/mL of EGF had the greatest percentage of wound fill, but no statistically significant differences were observed between the EGF treatment groups. Data points represent mean values ± SEM of 3 determinations. A 1-factor ANOVA was used to compare treatment groups at each SM concentration.


Addition of epidermal growth factor improves the rate of sulfur mustard wound healing in an in vitro model.

Henemyre-Harris CL, Adkins AL, Chuang AH, Graham JS - Eplasty (2008)

NHEK cells exposed to 5 μM of SM and treated with EGF. Cells were treated daily with 0, 1, 10, or 20 ng/mL of EGF and stained with 0.1% crystal violet 6 days after wounding. For 0 μM of SM, a significant difference* (P ≤ .05) in wound fill was observed between the cells treated with 0 ng/mL of EGF and the 1, 10, and 20 ng/mL of EGF groups. For 5 μM of SM, cells treated with 1 ng/mL of EGF had the greatest percentage of wound fill, but no statistically significant differences were observed between the EGF treatment groups. Data points represent mean values ± SEM of 3 determinations. A 1-factor ANOVA was used to compare treatment groups at each SM concentration.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2289780&req=5

Figure 1: NHEK cells exposed to 5 μM of SM and treated with EGF. Cells were treated daily with 0, 1, 10, or 20 ng/mL of EGF and stained with 0.1% crystal violet 6 days after wounding. For 0 μM of SM, a significant difference* (P ≤ .05) in wound fill was observed between the cells treated with 0 ng/mL of EGF and the 1, 10, and 20 ng/mL of EGF groups. For 5 μM of SM, cells treated with 1 ng/mL of EGF had the greatest percentage of wound fill, but no statistically significant differences were observed between the EGF treatment groups. Data points represent mean values ± SEM of 3 determinations. A 1-factor ANOVA was used to compare treatment groups at each SM concentration.
Bottom Line: EGF (1 ng/mL) significantly increased wound fill on all of the days tested (days 6, 9, and 12).KGF did not significantly improve wound healing.These results will be used to develop a dressing that can slowly release EGF on to a debrided wound bed to help speed the healing process.

View Article: PubMed Central - PubMed

Affiliation: Physiology and Immunology Branch, Research Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, USA. claudia.henemyre@us.army.mil

ABSTRACT

Objective: Sulfur mustard (SM) causes blisters on the human skin. These blisters delay healing of the skin and make the victims more susceptible to infection. In vitro models have been used for protection studies against SM injury, but study on wound healing after SM exposure has not been explored. The purpose of this study was to test whether the addition of exogenous growth factors could improve the rate of SM wound healing.

Methods: The model consisted of normal human epidermal keratinocytes seeded into 6-well plates, exposed to SM, and wounded (disruption of the cell monolayer) with a sterile wounding instrument. Cells were then stained and images were captured to measure percentage wound fill. Epidermal growth factor (EGF) and keratinocyte growth factor (KGF) were tested in this model.

Results: EGF (1 ng/mL) significantly increased wound fill on all of the days tested (days 6, 9, and 12). KGF did not significantly improve wound healing.

Conclusions: EGF showed promise as a potential therapy for SM-induced wounds. This in vitro model was a valuable tool for screening therapeutics before animal testing. These results will be used to develop a dressing that can slowly release EGF on to a debrided wound bed to help speed the healing process.

No MeSH data available.


Related in: MedlinePlus